Showing results (1231-1240 of 3,105) with videos related to
Sort By:
Pageof 311
Drug Safety|June 24, 2017
Natural Language Processing for EHR-Based Pharmacovigilance: A Structured ReviewYuan Luo, William K Thompson, Timothy M Herr, et al.Drug Safety|June 28, 2017
Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from GhanaGeorge Tsey Sabblah, Delese Mimi Darko, Hudu Mogtari, et al.Drug Safety|July 7, 2017
Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance DatabaseAlice Capogrosso Sansone, Irma Convertino, Maria Teresa Galiulo, et al.Drug Safety|July 1, 2017
Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting DatabaseCécile Pageot, Julien Bezin, Andy Smith, et al.Drug Safety|May 5, 2018
Exploring the Potential Routine Use of Electronic Healthcare Record Data to Strengthen Early Signal Assessment in UK Medicines Regulation: Proof-of-Concept StudyKatherine Donegan, Rebecca Owen, Helena Bird, et al.Drug Safety|May 25, 2019
Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine LearningTimothé Ménard, Yves Barmaz, Björn Koneswarakantha, et al.Drug Safety|May 10, 2019
Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY StudyEstelle Guiard, Bénédicte Lelievre, Magali Rouyer, et al.Drug Safety|May 2, 2019
Correction to: Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor AgonistsRasmus M Christensen, Christian R Juhl, Signe S TorekovDrug Safety|October 12, 2017
Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in EnglandVicki Osborne, Miranda Davies, Deborah Layton, et al.Drug Safety|December 16, 2019
The Use of Long-Acting Insulin Analogs and the Risk of Colorectal Cancer Among Patients with Type 2 Diabetes: A Population-Based Cohort StudyRicheek Pradhan, Hui Yin, Oriana H Y Yu, et al.Pageof 311